|
1. Arai H, Hori S, Aramori I, Ohkubo H, Nakanishi S: Cloning and expression of cDNA encoding and endothelin receptor. Nature. 1990;348:730-732. 2. Baillie GM, Sherer JT, Weart CW: Insulin and coronary artery disease: is syndrome X the unifying hypothesis? Ann Pharmacother. 1998;32:233-247. 3. BergerJ, Biswas C, Vicario PP, Strout HV, Saperstein R, Pilch PF: Decreased expression of the insulin-responsive glucose transporter in diabetes and fasting. Nature. 1989;340:70-72. 4. Bonora E, Willeit J, Egger G, Targher G, Bonadonna RC, Muggeo M: Prevalence of insulin resistance in metabolic disorders. Diabetes. 1998;47:1643-1649. 5. Bursztyn M, Ben-Ishay D, Mekler J, Raz I: Chronic exogenous hyperinsulinemia accelerates the development of hypertension in spontaneously hypertensive rats. Clin Exp Pharmacol Physiol.1998;1(suppl):S28-S29. 6. Cardillo C, Nambe SS, Choucair WK, Katz A, Quon MJ, Panza JA: Insulin stimulates both endothelin and nitric oxide activity in the human forearm. Circulation. 1999;100:820- 825. 7. Cheatham B, Kahn CR: Insulin action and the insulin signaling network. Endocr Rev. 1995;16:117-142. 8. Chou YC, Perng JC, Juan CC, Jang SY, Kwok CF, Chen WL, Fong JC, Ho LT: Endothelin-1 inhibits insulin-stimulated glucose uptake in isolated rat adipocytes. Biochem Biophys Res Commun. 1994;2002:688-693. 9. Davenport AP, Nunez DJ, Hall JA, Kaumann AJ, Brown MJ: Autoradiographical localization of binding sites for porcine [125I]endothelin-1 in humans, pigs, and rats: functional relevance in humans. J Cardiovasc Pharmacol. 1989;13(suppl 5):S166-S170. 10.Feener EF, King GL: Vascular dysfunction in diabetes mellitus. Lancet. 1997;350(suppl I):9-13. 11.Garvey WT, Olefsky JM, Matthaei S, Marshall S: Glucose and insulin co-regulate the glucose transport system in primary cultured adipocytes. A new mechanism of insulin resistance. J Biol Chem. 1987;262:189-197. 12.Hopfner RL, Hasnadka RV, Wilson TW, Mcneill JR, Gopalakrishnan V: Insulin increases endothelin-1-evoked intracellular free calcium responses by increased ETA receptor expression in rat aortic smooth muscle cells. Diabetes. 1998;47:937-944. 13.Huang WC, Fang TC: Angiotensin receptor blockade blunts hyperinsulinemia-induced hypertension in rats. Hypertension. 1998;32:235-242. 14.Jiang ZY, Zhou QL, Feener EF, White MF, King GL: Endothelin- 1 modulates insulin signaling through phosphatdylinositol 3- kinase pathway in vascular smooth muscle cells. Diabetes. 1999;48:1120-1130. 15.Juan CC, Fang VS, Huang YJ, Kwok CF, Hsu YP, Ho LT: Endothelin-1 induces insulin resistance in conscious rats. Biochem Biophys Res Commun. 1996;227:694-699. 16.Juan CC, Fang VS, Kowk CF, Perng JC, Chou YC, Ho LT: Exogenous hyperinsulinemia causes insulin resistance, hyperendothelinemia, and subsequent hypertension in rats. Metabolism. 1999;227:694-699. 17.Kahn CR, Baird KL, Flier JS, Grunfeld C, Harmon JT, Harrison LC, Karlsson FA, Kasuga M, King GL, Lang UC, Podskalny JM, VanObberghen E: Insulin receptors, receptor antibodies, and the mechanism of insulin action. Recent Prog Horm Res. 1981;37:477-538. 18.Kahn CR, White MF: The insulinreceptor and the molecular mechanism of insulin action. J Clin Invest. 1988;82:1151- 1156. 19.Kahn CR: Insulin action, diabetogenes, and the cause of type II diabetes. Diabetes. 1994;43:1066-1084. 20.Kahn CR: Insulin resistance, insulin insensitivity, and insulin unresponsiveness: a necessary distinction. Metabolism. 1978;27:1893-1902. 21.Katakam PVG, Ujhelyi MR, Hoenig M, Miller AW: Metformin improves vascular function in insulin-resistance rats. Hypertension. 2000;35:108-112. 22.King GL, Goodman D, Buzney S, Moses A, Kahn CR: Receptors and growth-promoting effects of insulin and insulin-like growth factors on cells from bovine retinal capillaries and aorta. J Clin Invest. 1996;71:1167-1176. 23.Kuboki K, Jiang ZY, Takahara N, Ha SW, Igarashi M, Yamauchi T, Feener EF, Herbert TP, Rhodes CJ, King GL: Regulation of endothelial constitutive nitric oxide synthase gene expression in endothelial cells and in vivo. Circulation. 2000;101: 676-681. 24.Meehan WP, Buchanan TA, Hsueh W: Chronic insulin administration elevates blood pressure in rats. Hypertension. 1994;23(pt 2):1012-1017. 25.Miller AW, Katakam PVG, Ujhelyi MR: Impaired endothelium- mediated relaxation in coronary arteries from insulin- resistant rats. J Vasc Res. 1999;36:385-392. 26.Mitsutomi N, Akashi C, Odagiri J, Matsumura Y: Effects of endogenous and exogenous nitric oxide on endothelin-1 production in cultured vascular endothelial cells. European Journal of pharmacology. 1999;364:65-73. 27.Modan M, Halkin H, Almog S, Lusky A, Eshkol M, Shitrit A, Fuchs Z: Hyperinsulinemia: a link between hypertension, obesity and glucose intolerance. J Clin Invest. 1985;75:809- 817. 28.Moller DE, Flier JS: Insulin resistance mechanism, syndromes and implications. N Engl J Med. 1991;325:938-938. 29.Murad F. Nitric oxide signaling: would you believe that a simple free radical could be a second messenger, autacoid, paracrine substance, neurotransmitter, and hormone? Recent progress in hormone research. 1998; 53:43-59. 30.Olefsky JM, Kolterman OG: Mechanisms of insulin resistance in obesity and noninsulin-dependent (type II) diabetes. Am J Med. 1981;70:151-168. 31.Olefsky JM: Insulin resistance and insulin action. An invitro and in vivo perspective. Diabetes. 1981;30:148-162. 32.Oliver FJ, Feener EF, Lee ME, Loeken MR, Shiba T, Quertermous T, King GL: Stimulation of endothelin-1 gene expression by insulin in endothelial cells. J Biol Chem. 1991;266:23251-23256. 33.Porte DJ: Beta-cells in type II diabetes mellitus. Diabetes. 1991;40:166-180. 34.Prie S, Stewart DJ, Dupuis J. EndothelinA receptor blockade improves nitric oxide-mediated vasodilation in monocrotaline- induced pulmonary hypertension. Circulation. 1998; 97:2169- 2174. 35.Reaven GM: Role of insulin resistance in human disease. Diabetes. 1988;37:1595-1607. 36.Rosen OM: After insulin binds. Science. 1987;237:1252-1258. 37.Sasaki A, Horiuchi N, Hasegawa K, Uehara M: Mortality and causes of death in type 2 diabetic patients. A long-term follow-up study in Osaka district, Japan. Diabetes Res Clin Pract. 1989;7:33-40. 38.SimonsonMS, Dunn MJ: Endothelin. Pathways of transmembrane signaling. Hypertension. 1990;15:I5-I12. 39.Steinberg HO, Paradisi G, Hook G, Crowder K, Cronin J, Baron AD: Free fatty acid elevation impairs insulin-mediated vasodilatation and nitric oxide production. Diabetes. 2000;49:1231-1238. 40.Takahashi K, Ghatei MA, Lam HC, O’Halloran DJ, Bloom SR: Elevated plasma endothelin in patients with diabetes mellitus. Diabetologia. 1990;33:306-310. 41.Traxinger RR, Marshall S: Glucose regulation of insulin receptor affinity in primary cultured adipocytes. J Biol Chem. 1990;265:18879-18883. 42.Traxinger RR, Marshall S: Recovery of maximal insulin responsiveness and insulin sensitivity after induction of insulin resistance in primary cultured adipocytes. J Biol Chem. 1989;264:8156-8163. 43.Turner R, Hattersley A, Cook J: Type II diabetes: search for primary defects. Ann Med 1992;24:511-516. 44.Yanagisawa M, Kurihara J, Kimuras S, Tomobe Y, Kobayashi M, Mitsui Y, Yazaki Y Goto K, Masaki T: A novel potent vasoconstrictor peptide produced by vascular endothelial cells. Nature. 1988;332:411-415.
|